Market openADR

Sanofi/SNY

13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX

About Sanofi

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Ticker

SNY
Trading on

Industry

Pharmaceuticals
Headquarters

Employees

86,088

Sanofi Metrics

BasicAdvanced
$139B
Market cap
15.00
P/E ratio
$3.68
EPS
0.41
Beta
$1.48
Dividend rate
2.68%
Dividend yield
$139B
0.41
$58.15
$42.63
1.7M
$1.48
1.002
0.52
19.502
32.537
111.57%
14.02%
4.16%
5.81%
14.997
1.34
1.74
28.2
15.246
2.68%
2.68%
2.25%
-50.93%
7.83%
-9.85%
5.52%

What the Analysts think about Sanofi

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Sanofi stock.

Sanofi Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Sanofi Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy SNY

$

Sign up or log in to buy
Market openADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Sanofi stock?

Sanofi (SNY) has a market cap of $139B as of October 10, 2024.

What is the P/E ratio for Sanofi stock?

The price to earnings (P/E) ratio for Sanofi (SNY) stock is 15 as of October 10, 2024.

Does Sanofi stock pay dividends?

Yes, the Sanofi (SNY) stock pays dividends to shareholders. As of October 10, 2024, the dividend rate is $1.47849 and the yield is 2.68%. Sanofi has a payout ratio of 111.57% on a trailing twelve-month basis.

When is the next Sanofi dividend payment date?

The next Sanofi (SNY) dividend payment date is unconfirmed.

What is the beta indicator for Sanofi?

Sanofi (SNY) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.